Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.

Kidney transplant access in the Southeast: view from the bottom. Am J Transplant (2014) 1.71

Association between urinary albumin excretion and coronary heart disease in black vs white adults. JAMA (2013) 1.65

Addressing health disparities in chronic kidney disease. Int J Environ Res Public Health (2014) 0.85

Disparities in the burden, outcomes, and care of chronic kidney disease. Curr Opin Nephrol Hypertens (2014) 0.84

The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey. PLoS One (2016) 0.75

US Mortality: Influence of Race, Geography and Cardiovascular Risk Among Participants in the Population-Based REGARDS Cohort. J Racial Ethn Health Disparities (2015) 0.75

Evolution of research in health geographics through the International Journal of Health Geographics (2002-2015). Int J Health Geogr (2016) 0.75

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q (1971) 13.96

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

The Latino mortality paradox: a test of the "salmon bias" and healthy migrant hypotheses. Am J Public Health (1999) 6.61

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28

Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med (2011) 2.28

What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol (2012) 2.27

Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS Data Brief (2010) 2.22

White/black racial differences in risk of end-stage renal disease and death. Am J Med (2009) 2.16

Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71

Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis (2010) 1.68

Chronic kidney disease in the urban poor. Clin J Am Soc Nephrol (2010) 1.61

Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: the REasons for Geographic And Racial Differences in Stroke Study. Stroke (2008) 1.39

Poverty and racial disparities in kidney disease: the REGARDS study. Am J Nephrol (2010) 1.38

Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens (2010) 1.29

Birth and adult residence in the Stroke Belt independently predict stroke mortality. Neurology (2009) 1.28

Childhood residential stability and health at midlife. Am J Public Health (2003) 1.15

Regional variations in the incidence of end-stage renal failure in Japan. JAMA (2000) 1.11

Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction. Am J Kidney Dis (2008) 1.02

Epidemiology, geography and chronic kidney disease. Curr Opin Nephrol Hypertens (2012) 0.97

The directionality and age selectivity of the health-migration relation: evidence from sequences of disability and mobility in the United States. Int Migr Rev (1988) 0.97

Population genetics of chronic kidney disease: the evolving story of APOL1. J Nephrol (2012) 0.96

Lifetime residential mobility history and self-rated health at midlife. J Epidemiol (2011) 0.95

Residential mobility and urban-rural residence within life stages related to health risk and chronic disease in Tecumseh, Michigan. J Chronic Dis (1982) 0.89

Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes. Am J Kidney Dis (1995) 0.80

Geographic differences in the increasing ESRD rate have disappeared in Japan. Clin Exp Nephrol (2011) 0.79

Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72

Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med (2008) 9.95

Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med (2005) 8.95

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90

Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med (2011) 8.54

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA (2004) 7.35

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88

Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol (2011) 5.46

The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45

Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (2012) 4.25

Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01

Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77

New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care (2009) 3.73

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63

Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 3.62

Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52

Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med (2011) 3.49

Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47

Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev (2008) 3.44

Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation (2005) 3.38

Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med (2006) 3.38

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11

Vascular access and increased risk of death among hemodialysis patients. Kidney Int (2002) 3.10

Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07

Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06

Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05

Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol (2002) 3.04

Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med (2008) 2.99

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med (2003) 2.94

Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol (2004) 2.91

Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) (2012) 2.85

Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83

Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med (2014) 2.81

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol (2008) 2.68

Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med (2003) 2.66

Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66

Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care (2009) 2.58

A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57

Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med (2013) 2.55

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51

Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50

Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49

Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol (2005) 2.49

Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol (2009) 2.45

Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol (2002) 2.43

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43